Login to Your Account



Economy Is to Blame

hESC Therapy Pioneer Geron Abandons Stem Cell R&D

By Nuala Moran
BioWorld Today Correspondent

Wednesday, November 16, 2011

After 15 years' effort, the world pioneer of human embryonic stem cell (hESC) therapy, Geron Inc., is abandoning the field and will be stopping recruitment to its ground-breaking Phase I acute spinal injury trial.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription